{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:49:15Z","timestamp":1790290155981,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["20-15-00235"],"award-info":[{"award-number":["20-15-00235"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.diagmicrobio.2023.116102","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T06:12:59Z","timestamp":1696918379000},"page":"116102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clonal diversity, antimicrobial resistance, and genome features among nonfermenting gram-negative bacteria isolated from patients with cystic fibrosis in Russia"],"prefix":"10.1016","volume":"108","author":[{"given":"Yuliya","family":"Bocharova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6691-2171","authenticated-orcid":false,"given":"Igor","family":"Chebotar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-5098","authenticated-orcid":false,"given":"Tatiana","family":"Savinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Lyamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kondratenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Polikarpova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6244-4182","authenticated-orcid":false,"given":"Natalia","family":"Fedorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1419-6756","authenticated-orcid":false,"given":"Sergey","family":"Semykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-2550","authenticated-orcid":false,"given":"Dmitriy","family":"Korostin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1377-7153","authenticated-orcid":false,"given":"Andrey","family":"Chaplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy","family":"Shagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8077-5313","authenticated-orcid":false,"given":"Nikolay","family":"Mayanskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.diagmicrobio.2023.116102_bib0001","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcf.2020.02.015","article-title":"Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease","volume":"19","author":"Kapnadak","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diagmicrobio.2023.116102_bib0002","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3389\/fimmu.2018.03067","article-title":"Viral-bacterial co-infections in the cystic fibrosis respiratory tract","volume":"9","author":"Kiedrowski","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2023.116102_bib0003","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13104-020-05163-6","article-title":"Emergence of multidrug-resistant non-fermentative gram negative bacterial infection in hospitalized patients in a tertiary care center of Nepal","volume":"13","author":"Yadav","year":"2020","journal-title":"BMC Res Notes"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2023.116102_bib0004","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01025-20","article-title":"Achromobacter infections and treatment options","volume":"64","author":"Isler","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2023.116102_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5831139","article-title":"Distribution and characteristics of bacteria isolated from cystic fibrosis patients with pulmonary exacerbation","volume":"2022","author":"Erfanimanesh","year":"2022","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2023.116102_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01541-19","article-title":"Susceptibility of Pseudomonas aeruginosa recovered from cystic fibrosis patients to murepavadin and 13 comparator antibiotics","volume":"64","author":"Ekkelenkamp","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2023.116102_bib0007","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00019-18","article-title":"Epidemiology, biology, and impact of clonal Pseudomonas aeruginosa infections in cystic fibrosis","volume":"31","author":"Parkins","year":"2018","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2023.116102_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2021.115454","article-title":"Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection","volume":"101","author":"Rosales-Reyes","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2023.116102_bib0009","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/s12879-020-05338-3","article-title":"Fatal respiratory infection due to ST308 VIM-1-producing Pseudomonas aeruginosa in a lung transplant recipient: case report and review of the literature","volume":"20","author":"Carugati","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2023.116102_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106196","article-title":"Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired \u03b2-lactamases: 2020 update","volume":"56","author":"Del Barrio-Tofino","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2023.116102_bib0011","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/genes8010039","article-title":"The complex relationship between virulence and antibiotic resistance","volume":"8","author":"Schroeder","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.diagmicrobio.2023.116102_bib0012","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.micres.2014.06.007","article-title":"Type IV secretion systems and genomic islands-mediated horizontal gene transfer in Pseudomonas and Haemophilus","volume":"170","author":"Juhas","year":"2015","journal-title":"Microbiol Res"},{"key":"10.1016\/j.diagmicrobio.2023.116102_bib0013","unstructured":"Report of the UK Cystic Fibrosis Trust Microbiology Laboratory Standards Working Group. 2010. Laboratory standards for processing microbiological samples from people with cystic fibrosis. Available from: https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2020-12\/Laboratory%20standards.pdf [9th January 2020]."},{"issue":"3","key":"10.1016\/j.diagmicrobio.2023.116102_bib0014","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.mimet.2013.09.020","article-title":"Improvements on colony morphology identification towards bacterial profiling","volume":"95","author":"Sousa","year":"2013","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.diagmicrobio.2023.116102_bib0015","unstructured":"Clinical and Laboratory Standards Institute. 2020. Performance standards for antimicrobial susceptibility testing. Available from: http:\/\/em100.edaptivedocs.net\/Login.aspx [15th May 2023]."},{"key":"10.1016\/j.diagmicrobio.2023.116102_bib0016","unstructured":"European Cystic Fibrosis Society. 2022. ECFS Patient Registry Annual Report 2020. Available from: https:\/\/www.ecfs.eu\/projects\/ecfs-patient-registry\/annual-reports [20th May 2023]."},{"issue":"Suppl 3","key":"10.1016\/j.diagmicrobio.2023.116102_bib0017","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12864-018-4472-9","article-title":"On Burkholderiales order microorganisms and cystic fibrosis in Russia","volume":"19","author":"Voronina","year":"2018","journal-title":"BMC Genomics"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2023.116102_bib0018","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1469-0691.2011.03627.x","article-title":"Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates","volume":"18","author":"Tramper-Stranders","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2023.116102_bib0019","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jcf.2022.11.001","article-title":"Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis","volume":"22","author":"Kerem","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2023.116102_bib0020","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1128\/JCM.01360-13","article-title":"Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis","volume":"51","author":"Ramsay","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2023.116102_bib0021","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1513\/AnnalsATS.202003-204OC","article-title":"Clinical outcomes associated with Burkholderia cepacia complex infection in patients with cystic fibrosis","volume":"17","author":"Somayaji","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.diagmicrobio.2023.116102_bib0022","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3389\/fmicb.2017.01592","article-title":"Burkholderia cenocepacia infections in cystic fibrosis patients: drug resistance and therapeutic approaches","volume":"8","author":"Scoffone","year":"2017","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2023.116102_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02142-19","article-title":"Hypermutator Pseudomonas aeruginosa exploits multiple genetic pathways to develop multidrug resistance during long-term infections in the airways of cystic fibrosis patients","volume":"64","author":"Colque","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2023.116102_bib0024","unstructured":"The Comprehensive Antibiotic Resistance Database, 2020. Available from: https:\/\/card.mcmaster.ca\/ [25th May 2023]."},{"issue":"11","key":"10.1016\/j.diagmicrobio.2023.116102_bib0025","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1128\/AAC.01046-16","article-title":"Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Northern Europe","volume":"60","author":"Mustafa","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2023.116102_bib0026","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ijantimicag.2019.02.022","article-title":"Phylogenetic analysis of resistance to ceftazidime\/avibactam, ceftolozane\/tazobactam and carbapenems in piperacillin\/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients","volume":"53","author":"Zamudio","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2023.116102_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04478-22","article-title":"Global increase of antibiotic resistance genes in conjugative plasmids","volume":"11","author":"Wang","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2023.116102_bib0028","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1139\/cjm-2018-0275","article-title":"Horizontal transfer of antibiotic resistance genes in clinical environments","volume":"65","author":"Lerminiaux","year":"2019","journal-title":"Can J Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2023.116102_bib0029","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12866-017-0986-6","article-title":"Identification and analysis of genomic islands in Burkholderia cenocepacia AU 1054 with emphasis on pathogenicity islands","volume":"17","author":"Guo","year":"2017","journal-title":"BMC Microbiol"},{"issue":"Pt 3","key":"10.1016\/j.diagmicrobio.2023.116102_bib0030","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1099\/jmm.0.036822-0","article-title":"Insertion sequence evolutionary patterns highlight convergent genetic inactivations and recent genomic island acquisitions among epidemic Burkholderia cenocepacia","volume":"61","author":"Graindorge","year":"2012","journal-title":"J Med Microbiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889323002110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889323002110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:02:35Z","timestamp":1778752955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889323002110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0732889323002110"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2023.116102","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal diversity, antimicrobial resistance, and genome features among nonfermenting gram-negative bacteria isolated from patients with cystic fibrosis in Russia","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2023.116102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116102"}}